Anlotinib therapy for recurrent and progressive atypical meningioma: A case report

Asian J Surg. 2023 Nov;46(11):4812-4813. doi: 10.1016/j.asjsur.2023.05.103. Epub 2023 Jun 1.

¹ Department of Radiation Oncology, The Third Affiliated Hospital of Shenzhen University (Shenzhen Luohu People's Hospital), Shenzhen, Guangdong, China.
² Department of Radiation Oncology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China.
³ Department of Radiation Oncology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China. Electronic address: jiangxiwu84@126.com.

No abstract available

Keywords: Atypical meningioma; PDGFRA; anlotinib; case report; reccurence.

Publication types